The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre

Hdl Handle:
http://hdl.handle.net/10147/326382
Title:
The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre
Authors:
McVeigh, Terri Patricia; Hughes, Lauren M.; Miller, Nicola; Sheehan, Margaret; Keane, Maccon; Sweeney, Karl J.; Kerin, Michael J.
Citation:
McVeigh TP et al. The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre. Eur J Cancer 2014 [article in press 3 August 2014]
Publisher:
European Journal of Cancer
Journal:
European Journal of Cancer
Issue Date:
Sep-2014
URI:
http://hdl.handle.net/10147/326382
DOI:
10.1016/j.ejca.2014.08.002
Additional Links:
http://linkinghub.elsevier.com/retrieve/pii/S0959804914008818
Item Type:
Article In Press
Language:
en
Description:
A cohort study was undertaken, including consecutive patients with early node- negative, ER-positive breast cancer diagnosed between 2006 and May 2013, including a period of prospective clinical trial (Trial Assigning Individualised Options for Treatment (TAILORx)) recruitment. Data were collected regarding patient demographics, tumour clinic- o-pathological features, Oncotype DX use and recurrence score and chemotherapy use. All therapeutic decisions were made following multidisciplinary discussion, with adherence to guidelines and consideration of trial protocol and Oncotype DX recurrence scores.
Keywords:
BREAST CANCER
ISSN:
09598049

Full metadata record

DC FieldValue Language
dc.contributor.authorMcVeigh, Terri Patriciaen_GB
dc.contributor.authorHughes, Lauren M.en_GB
dc.contributor.authorMiller, Nicolaen_GB
dc.contributor.authorSheehan, Margareten_GB
dc.contributor.authorKeane, Macconen_GB
dc.contributor.authorSweeney, Karl J.en_GB
dc.contributor.authorKerin, Michael J.en_GB
dc.date.accessioned2014-09-22T14:11:17Zen
dc.date.available2014-09-22T14:11:17Zen
dc.date.issued2014-09en
dc.identifier.citationMcVeigh TP et al. The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre. Eur J Cancer 2014 [article in press 3 August 2014]en_GB
dc.identifier.issn09598049en
dc.identifier.doi10.1016/j.ejca.2014.08.002en
dc.identifier.urihttp://hdl.handle.net/10147/326382en
dc.descriptionA cohort study was undertaken, including consecutive patients with early node- negative, ER-positive breast cancer diagnosed between 2006 and May 2013, including a period of prospective clinical trial (Trial Assigning Individualised Options for Treatment (TAILORx)) recruitment. Data were collected regarding patient demographics, tumour clinic- o-pathological features, Oncotype DX use and recurrence score and chemotherapy use. All therapeutic decisions were made following multidisciplinary discussion, with adherence to guidelines and consideration of trial protocol and Oncotype DX recurrence scores.en_GB
dc.language.isoenen
dc.publisherEuropean Journal of Canceren_GB
dc.relation.urlhttp://linkinghub.elsevier.com/retrieve/pii/S0959804914008818en_GB
dc.rightsArchived with thanks to European Journal of Canceren_GB
dc.subjectBREAST CANCERen_GB
dc.titleThe impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centreen_GB
dc.typeArticle In Pressen
dc.identifier.journalEuropean Journal of Canceren_GB
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.